Q3 2025 Holdings
Filed 2025-11-14 | 33 holdings | $1.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $337.4M | 8,493,321 | 19.0% |
| Metsera Inc | COM | 59267L107 | $196.3M | 3,750,662 | 11.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $153.9M | 13,161,462 | 8.7% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $90.7M | 946,788 | 5.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $83.8M | 3,882,709 | 4.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $82.0M | 6,728,985 | 4.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $79.8M | 4,148,428 | 4.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $79.2M | 6,596,885 | 4.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $66.0M | 3,226,331 | 3.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $57.4M | 4,000,000 | 3.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $49.6M | 15,561,500 | 2.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $49.0M | 576,729 | 2.8% |
| Savara Inc(SVRA) | COM | 805111101 | $45.3M | 12,681,043 | 2.5% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $45.0M | 2,685,448 | 2.5% |
| Erasca Inc(ERAS) | COM | 29479A108 | $38.9M | 17,857,083 | 2.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $37.8M | 960,803 | 2.1% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $34.5M | 5,046,414 | 1.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $31.9M | 1,230,769 | 1.8% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $27.8M | 3,220,364 | 1.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $27.5M | 2,173,913 | 1.5% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $24.4M | 499,966 | 1.4% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $22.0M | 1,169,298 | 1.2% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $20.1M | 4,631,216 | 1.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $17.9M | 2,457,348 | 1.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $16.8M | 674,599 | 0.9% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $16.5M | 1,387,864 | 0.9% |
| Septerna Inc(SEPN) | COM | 81734D104 | $11.5M | 610,808 | 0.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $8.2M | 1,379,965 | 0.5% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $8.2M | 632,931 | 0.5% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $8.0M | 750,000 | 0.4% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $4.6M | 1,609,569 | 0.3% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $3.3M | 437,708 | 0.2% |
| Casi Pharmaceuticals Inc(CASIF) | ORD SHS | G1933S101 | $1.6M | 987,259 | 0.1% |